🇺🇸 FDA
Patent

US 8252338

Synthetic LDL as targeted drug delivery vehicle

granted A61KA61K38/16A61K38/164

Quick answer

US patent 8252338 (Synthetic LDL as targeted drug delivery vehicle) held by The Regents of the University of California expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/16, A61K38/164, A61K9/1275, A61P